Clinical Trials Logo

Filter by:
NCT ID: NCT01458548 Terminated - Clinical trials for Post-transplantation Lymphoproliferative Disorder

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Start date: December 2002
Phase: Phase 2
Study type: Interventional

Post-transplantation lymphoproliferative disorder (PTLD) develops in one to ten per cent of transplant recipients and can be EBV-associated. To improve long-term efficacy after rituximab monotherapy and to avoid the toxicity of CHOP seen in first-line treatment, the investigators initiated an international multicentre phase II trial to test whether the subsequent application of rituximab and four courses of three-weekly CHOP would improve the outcome of patients with PTLD: PTLD-1, sequential treatment (ST).

NCT ID: NCT01457872 Completed - Clinical trials for Substance Use Disorders

Malmö Treatment Referral and Intervention Study

MATRIS
Start date: October 2011
Phase: N/A
Study type: Interventional

This study aims to study and implement active referral of heroin users from a syringe exchange programme to evidence-based treatment for heroin addiction. Patients are randomized to either a strength-based case management intervention or a control group, while both groups receive referral to medical investigation for inclusion in substitution treatment for heroin addiction. The hypothesis is that syringe exchange can be used for referral to effective treatment, and that a strength-based intervention can increase the number of patients who are successfully referred and enter treatment.

NCT ID: NCT01457768 Completed - Clinical trials for Hepatitis C, Chronic

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

Start date: December 19, 2011
Phase:
Study type: Observational

This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.

NCT ID: NCT01457755 Completed - Clinical trials for Hepatitis C, Chronic

Gilead Sustained Virologic Response (SVR) Registry

Start date: April 13, 2012
Phase:
Study type: Observational

This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV.

NCT ID: NCT01457547 Completed - Hepatitis B Clinical Trials

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

Start date: October 2003
Phase: Phase 4
Study type: Interventional

The study will compare the immunogenicity and the reactogenicity of INFANRIX™ HEXA and HEXAVAC™ vaccines in a 3, 5 and 11 - 12 month vaccination schedule.

NCT ID: NCT01457482 Recruiting - Fear of Childbirth Clinical Trials

Art Therapy as Treatment for Fear of Childbirth

Start date: May 2011
Phase: N/A
Study type: Interventional

Earlier research has shown that pregnant women with a pronounced fear of childbirth have a significantly increased risk for birth complications and subsequent psychological trauma. In Sweden and also internationally, women in fear of childbirth are treated in many differing ways. Evidence for best care for these women is lacking. The Art Therapy method is a creative, psycho-therapeutic form of treatment which has been used for several decades within psychiatry. It has recently been seen that the Art Therapy method has positive effects during treatment for crisis reactions. Recruitment has recently been initiated for a randomized controlled study of Art Therapy for the treatment of fear of childbirth. The hypothesis for the study is as follows: H1 = treatment with Art Therapy and therapeutic conversations will result in a decrease in fear of childbirth when compared to treatment by therapeutic conversations only. The instrument which is to be used for measurement of childbirth fear is the Wijma Delivery Expectancy Questionnaire (W-DEQ). This is a well validated instrument which was developed in Sweden. A power calculation has shown a need for 62 x 2 participants; a total of 124 women.

NCT ID: NCT01457222 Unknown status - Stress Clinical Trials

Cognition and Health in Adolescents, Mindfulness as Prevention of Stress.

CHAMPS
Start date: October 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether mindfulness is useful as primary prevention for psychological health in highschool students, primarily related to stress, and whether mindfulness can improve cognitive function.

NCT ID: NCT01457209 Completed - Insulin Resistance Clinical Trials

Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome

PCOS-AcupIR
Start date: October 2011
Phase: Phase 1
Study type: Interventional

The central hypothesis is that acupuncture break the vicious circle of androgen excess and reverse insulin resistance and improve health related quality of life and affective symptoms in overweight and obese women with and without Polycystic Ovary Syndrome.

NCT ID: NCT01456559 Completed - Hypovolemia Clinical Trials

Detection of Hypovolemia Using Pleth Variability Index (PVI)

Start date: October 2011
Phase: N/A
Study type: Observational

The purpose with the planned study is to study Pleth Variability Index (PVI) as a non invasive indicator for mild hypovolemia during spontaneous breathing in healthy subjects. Lower body negative pressure (LBNP), a well established technique is used to create defined levels of hypovolemia. Primary hypothesis: By applying a breathing resistance (positive end expiratory pressure PEEP) to spontaneous breathing, the respiratory synchronous variation in the pulse oximeter signal (PVI) is enhanced and enables PVI to detect and grade the level of mild hypovolemia. Secondary hypothesis: 1) When tidal volume is increased, the respiratory synchronous variation in the pulse oximeter signal (PVI) will also increase. 2) The earlobe is superior to the finger in detecting PVI 3) Hemoglobin (Hb), detected non invasively by pulse oximetry, is not affected by hypovolemia created by LBNP

NCT ID: NCT01456169 Completed - Clinical trials for Essential Hypertension

A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

Start date: October 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of the fixed dose combinations of azilsartan medoxomil plus chlorthalidone (40/12.5 and 40/25 mg), once daily, in participants with grades 2 or 3 essential hypertension who do not reach target blood pressure following treatment with 40 mg azilsartan medoxomil monotherapy after 4 weeks.